Webinar: GLP-1s Without the Sticker Shock

Webinars On-Demand
GLP-1 webinar | LucyRx

How to Offer Access Without Blowing Your Budget 

GLP-1s Are Reshaping Prescription Care—Is Your Strategy Ready?

GLP-1s like Wegovy, Ozempic, and Mounjaro are everywhere—in renewal forecasts, inboxes, and budget conversations. But without a thoughtful strategy, costs can quickly spiral into your largest prescription care expense.

Don’t leave your GLP-1 strategy to chance.
Watch this expert-led webinar where a pharmacist, nurse, physician, and HR leader share practical steps employers can take to balance cost, access, and outcomes. Learn how to manage the GLP-1 surge with the right mix of clinical strategy, lifestyle support, and benefit design that works in the real world.

        Featuring expert insights from: 

        • Nicole Hancy, Sr. Director, Clinical Account Management, LucyRx 
        • Maggie Scott, VP, Strategic Solutions, Personify Health 
        • Dr. Jeffrey Jacques, Chief Medical Officer, Personify Health 
        • Dr. Mark Vasiladis, Family Practitioner at Executive Health Services 
        • Moderated by Lori Hart, CHRO, LucyRx 
        Watch the webinar

        GLP-1 Planning Checklist

        Don’t leave your GLP-1 strategy to chance. Download the GLP-1 Planning Checklist to find high-impact changes that protect budgets and improve outcomes.

        Download the Checklist

        Recommended Reads

        Business benefits professionals reviewing pharmacy benefit options and partnership requirements for employer health plans.

        What Makes a Pharmacy Benefit Solution Easier for TPAs to Stand Behind?

        Third-party administrators put their own client relationships at stake when recommending a pharmacy benefit manager. Learn which capabilities help TPAs evaluate PBM partners, explain benefit strategies confidently and maintain accountability from implementation through renewal.

        When Women’s Health Reaches the Prescription, the Pharmacy Benefit Still Has Work to Do

        Women’s health programs can improve clinical access, but prescription barriers can still interrupt treatment. Employers and benefits leaders should evaluate affordability, coverage, medication availability and how quickly access problems are resolved.
        Benefits professionals reviewing pharmacy benefit contract terms, data access and implementation requirements to assess how much control employers have over their PBM strategy.

        PBM Flexibility Is Not the Same as Control: What TPAs Should Test

        Pharmacy benefit options have limited value if contract restrictions or operational barriers prevent employers from using them. This article outlines how TPAs can assess decision-making information, contractual rights and implementation capabilities before recommending a PBM.
        Benefits and implementation teams reviewing a PBM transition plan, data requirements and go-live responsibilities before an employer pharmacy benefit launch.

        Implementation Is Part of the Sale: What TPAs Should Test Before Recommending a PBM

        A PBM transition can put a TPA’s client relationship at risk if eligibility errors, prescription disruptions or unclear responsibilities emerge at go-live. This checklist outlines five areas TPAs should test before recommending a PBM to an employer.
        Employer benefits leader evaluating specialty pharmacy performance, costs, access, and member outcomes

        How Should a Specialty Pharmacy Earn Its Role?

        Specialty pharmacy can materially affect employer plan costs, access, and treatment continuity. This article outlines the measures benefits leaders can use to evaluate pharmacy channels based on evidence rather than affiliation.

        Projected Savings vs. Realized Savings: What Employers Should Ask

        Employers need to know whether a pharmacy savings figure represents an opportunity or an actual result. This article explains how to evaluate savings methodology, assumptions, and outcomes.
        GLP-1 medication representing employer coverage and cost decisions

        A Better Way to Think About GLP-1 Strategy

        GLP-1 coverage no longer has to be an all-or-nothing decision. Employers can evaluate access, clinical support, costs, and benefit visibility to build a strategy that works for their plan and the people who rely on it.
        Woman with glucose monitor

        Diabetes Affordability is About More Than One Prescription

        Diabetes affordability extends beyond insulin. Learn how employers can evaluate medication costs, GLP-1s, monitoring devices, coverage rules, and member support across the full diabetes regimen.
        Pharmacist and Patient

        Is Your Pharmacy Benefit Still Working as Intended?

        A pharmacy benefit can perform as designed and still fall behind the market. Learn how employers can evaluate costs, member access, plan design, and PBM performance—and decide whether to stay, improve the current strategy, or explore a change.
        Doctors chart

        Disclosure Won. Now What?

        PBM transparency gives employers greater visibility into pharmacy costs—but disclosure is only the beginning. Learn how plan sponsors can turn better information into greater control, accountability, and measurable results.
        PreviousNext
        Business benefits professionals reviewing pharmacy benefit options and partnership requirements for employer health plans.

        What Makes a Pharmacy Benefit Solution Easier for TPAs to Stand Behind?

        Third-party administrators put their own client relationships at stake when recommending a pharmacy benefit manager. Learn which capabilities help TPAs evaluate PBM partners, explain benefit strategies confidently and maintain accountability from implementation through renewal.

        When Women’s Health Reaches the Prescription, the Pharmacy Benefit Still Has Work to Do

        Women’s health programs can improve clinical access, but prescription barriers can still interrupt treatment. Employers and benefits leaders should evaluate affordability, coverage, medication availability and how quickly access problems are resolved.
        Benefits professionals reviewing pharmacy benefit contract terms, data access and implementation requirements to assess how much control employers have over their PBM strategy.

        PBM Flexibility Is Not the Same as Control: What TPAs Should Test

        Pharmacy benefit options have limited value if contract restrictions or operational barriers prevent employers from using them. This article outlines how TPAs can assess decision-making information, contractual rights and implementation capabilities before recommending a PBM.
        Benefits and implementation teams reviewing a PBM transition plan, data requirements and go-live responsibilities before an employer pharmacy benefit launch.

        Implementation Is Part of the Sale: What TPAs Should Test Before Recommending a PBM

        A PBM transition can put a TPA’s client relationship at risk if eligibility errors, prescription disruptions or unclear responsibilities emerge at go-live. This checklist outlines five areas TPAs should test before recommending a PBM to an employer.
        Employer benefits leader evaluating specialty pharmacy performance, costs, access, and member outcomes

        How Should a Specialty Pharmacy Earn Its Role?

        Specialty pharmacy can materially affect employer plan costs, access, and treatment continuity. This article outlines the measures benefits leaders can use to evaluate pharmacy channels based on evidence rather than affiliation.

        Projected Savings vs. Realized Savings: What Employers Should Ask

        Employers need to know whether a pharmacy savings figure represents an opportunity or an actual result. This article explains how to evaluate savings methodology, assumptions, and outcomes.
        GLP-1 medication representing employer coverage and cost decisions

        A Better Way to Think About GLP-1 Strategy

        GLP-1 coverage no longer has to be an all-or-nothing decision. Employers can evaluate access, clinical support, costs, and benefit visibility to build a strategy that works for their plan and the people who rely on it.
        Woman with glucose monitor

        Diabetes Affordability is About More Than One Prescription

        Diabetes affordability extends beyond insulin. Learn how employers can evaluate medication costs, GLP-1s, monitoring devices, coverage rules, and member support across the full diabetes regimen.
        Pharmacist and Patient

        Is Your Pharmacy Benefit Still Working as Intended?

        A pharmacy benefit can perform as designed and still fall behind the market. Learn how employers can evaluate costs, member access, plan design, and PBM performance—and decide whether to stay, improve the current strategy, or explore a change.
        PreviousNext

        LucyRx is an independent, modern pharmacy benefit manager with the scale of an enterprise serving more than 9 million members nationwide.

        Follow us

        Linkedin Linkedin Tiktok Tiktok Instagram Instagram
        URAC Accreditation

        Copyright © 2026 by LucyRx. All Rights Reserved | Privacy Policy | Terms of Use | Members Rights

        Navigating ERISA for Employer Health Plans: A Guide for Smarter CompliancehandshakeGLP-1The Weight Loss Benefit Cost Paradox: What HR Leaders Need to Know

        Download the PBM Reform Readiness Checklist

        Download the GLP-1 Planning Checklist